North Star Investment Management’s Eterna Therapeutics ERNA Stock Holding History

North Star Investment Management’s Portfolio ERNA Stock Details ERNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Hold	0	–	-$3K	–	1193
2021 Q3	–	Hold	0	–	–	–	1008
2021 Q2	–	Sell	-1	Closed	-$144K	–	936
2021 Q1	$35K	Hold	1	–	–	﹤0.01%	622
2020 Q4	$43K	Hold	1	–	–	﹤0.01%	556
2020 Q3	$32K	Hold	1	–	–	﹤0.01%	582
2020 Q2	$42K	Sell	1 -20	-95%	-$434K	0.01%	521
2020 Q1	$477K	Hold	21	–	–	0.07%	221
2019 Q4	$691K	Sell	21 -1	-5%	-$42.6K	0.07%	237
2019 Q3	$1.09M	Hold	22	–	–	0.12%	197
2019 Q2	$1.22M	Buy	22 +1	+5%	+$52.4K	0.14%	183
2019 Q1	$1.26M	Buy	21 +1	+5%	+$47.9K	0.15%	175
2018 Q4	$585K	Hold	20	–	–	0.08%	234
2018 Q3	$1.32M	Hold	20	–	–	0.15%	175
2018 Q2	$1.31M	Hold	20	–	–	0.15%	177
2018 Q1	$2.03M	Hold	20	–	–	0.24%	116
2017 Q4	$1.26M	Buy	20 +3	+18%	+$237K	0.15%	171
2017 Q3	$1.58M	Hold	17	–	–	0.2%	135
2017 Q2	$1.68M	Buy	17 +4	+31%	+$432K	0.23%	126
2017 Q1	$1.72M	Buy	+13	New	+$1.5M	0.24%	116

Other funds holding ERNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CPWM

Cypress Point Wealth Management Dallas, Texas $492M AUM 22.57% 1-Year Est. Return

Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

North Star Investment Management's ERNA Position: Q4 2021 in Review

North Star Investment Management held its Eterna Therapeutics (ERNA) position steady in Q4 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

North Star Investment Management first reported a position in ERNA in Q1 2017 and has held it in 17 quarters since. The position peaked at $2.03M in Q1 2018. 47 funds tracked by Wall St. Rank hold ERNA as of Q4 2021.

North Star Investment Management held 0 shares of Eterna Therapeutics worth $0 as of Q4 2021.
North Star Investment Management left its Eterna Therapeutics share count unchanged in Q4 2021.
Eterna Therapeutics made up ﹤0.01% of North Star Investment Management's portfolio in Q4 2021, its #1193 holding.
North Star Investment Management first reported a position in Eterna Therapeutics in Q1 2017 and has held it in 17 quarters since.
North Star Investment Management's Eterna Therapeutics position peaked at $2.03M in Q1 2018.
47 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q4 2021.

Based on North Star Investment Management's 13F filing for Q4 2021, filed 7 Feb 2022.